Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Vivos Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 25 | 22 | −3 |
| Shares | 1.82M | 530.7K | −1.29M (−70.9%) |
| Value | $2.15M | $242.7K | −$1.90M (−88.7%) |
New holders (2)
Institutions that held Vivos Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 10,075 | $4.58K | 0.00% |
| Global Retirement Partners, LLC | 23 | $10 | 0.00% |
Sold out (5)
Institutions that held Vivos Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Armistice Capital, LLC | 1,115,859 | $1.32M |
| XTX Topco Ltd | 25,117 | $29.6K |
| Northwestern Mutual Wealth Management Co | 3 | $4 |
| Caitong International Asset Management Co., Ltd | 2 | $2 |
| Citigroup Inc | 1 | $1 |